Table 3.4.
Promoter | Specificity | Strength | Ref |
---|---|---|---|
Viral (CMV-IE, RSV-LTR, MoMLV-LTR, SV40) | Ubiquitous | +++ | (Papadakis, Nicklin, Baker, & White, 2004) |
Eukaryotic (EF1-α) | Ubiquitous | ++++ | (Xu et al., 2001) |
Ubiquitin C | Ubiquitous | + | (Qin et al., 2010) |
GUSB | Ubiquitous | + | (Husain, Passini, Parente, Fraser, & Wolfe, 2009) |
PPE | All of CNS | +++ | (Xu et al., 2001) |
SYN1 | Neurons | ++ | (Kugler et al., 2001) |
NSE | Neurons | ++++ | (Smith-Arica et al., 2000) |
GFAP | Astrocytes | +++ | (Lee, Messing, Su, & Brenner, 2008; Smith- Arica et al., 2000) |
MBP | Oligodendrocytes | ++ | (Gow, Friedrich, & Lazzarini, 1992) |
F4/80 | Microglia | ++ | (Cucchiarini, Ren, Perides, & Terwilliger, 2003) |
MCH | MCH neurons | ++ | (van den Pol, Acuna- Goycolea, Clark, & Ghosh, 2004) |
MeCP2 (MeP229) | Neurons | + | (Gray, Foti, et al., 2011) |
CMV, cytomegalovirus; RSV-LTR, Rous sarcoma virus long terminal repeat; SV40, simian virus 40; EF1-α, Human elongation factor-1 alpha promoter; PPE, preproenkephalin; GFAP, Glial fibrillary acidic protein.